← Back

LCI Industries

82.81-7.8%1Y · USD

LCI Industries manufactures and supplies engineered components for recreational vehicle (RV) manufacturers and adjacent industries in the United States and internationally. It operates through two segments: OEM and Aftermarket. The OEM segment produces a wide range of components, including steel chassis, axles, braking and suspension systems, leveling systems, awnings, windows, doors, steps, bath and kitchen products, furniture, appliances, electronics, and towing accessories, serving RV and adjacent industry manufacturers such as boats, buses, trailers, trucks, trains, manufactured homes, and modular housing. The Aftermarket segment supplies components to aftermarket channels for retail dealers, wholesale distributors, and service centers, as well as direct-to-consumer online sales, and also sells replacement glass, awnings, and various accessories. LCI Industries was formerly known as Drew Industries Incorporated and changed its name in December 2016. Founded in 1956, the company is headquartered in Elkhart, Indiana.

Price · split & dividend adjusted
News & notes moving LCII
United States
LCII▲3

LCI Industries lifts Q2 profit 13% despite RV slump, cuts full-year shipment outlook

LCI Industries reported a 13% rise in adjusted earnings per share to $2.70 for the second quarter of 2026, even as adjusted net sales fell 4% to $1.1 billion, driven by cost-cutting and higher product content. OEM net sales declined 10% while aftermarket sales grew 11%, and content per towable RV unit increased 11% to $5,831. The company lowered its full-year wholesale RV shipment guidance to 280,000–300,000 units and now expects adjusted revenue of $3.9 billion–$4.1 billion and adjusted EPS of $8.25–$8.75. LCI maintained its full-year adjusted operating margin target of 7.5%–8% and ended the quarter with $812 million in total liquidity. The proposed merger with Patrick Industries remains under regulatory review, with LCI continuing to operate normally.
LCII · Capital · Positive Q2 EPS rose 13% despite sales decline, driven by cost-cutting and higher content, though full-year guidance was cut.
PATK · Capital · Neutral Merger with LCI remains under regulatory review; no direct impact on Patrick Industries' operations.
Read original ↗
MarketBeat·58dRead more →
LCII

Halper Sadeh LLC Investigates PATK, AXTA, EQH Deals for Shareholder Fairness

Halper Sadeh LLC, an investor rights law firm, is investigating whether Patrick Industries, Axalta Coating Systems, and Equitable Holdings are obtaining fair deals for their shareholders. The firm is examining Patrick Industries' merger with LCI Industries, where Patrick shareholders would own approximately 52% of the combined company, Axalta's sale to Akzo Nobel for 0.6539 shares of AkzoNobel stock per Axalta share, and Equitable Holdings' merger with Corebridge Financial, exchanging each Equitable share for 1.55516 shares of the combined company, leaving Equitable shareholders with about 49% ownership. Halper Sadeh may seek increased consideration or additional disclosures on behalf of shareholders, and encourages them to contact the firm at no cost to discuss their legal rights and options.
AXTA · Capital · Neutral Axalta's sale to Akzo Nobel is being investigated for fairness; outcome could affect deal terms.
EQH · Capital · Neutral Equitable Holdings' merger with Corebridge Financial is under investigation for shareholder fairness.
PATK · Capital · Neutral Patrick Industries' merger with LCI Industries is being investigated for fairness.
AKZA.AS · Capital · Neutral Akzo Nobel is the acquirer in Axalta deal; investigation may affect transaction.
LCII · Capital · Neutral LCI Industries is the merger partner of Patrick Industries; investigation may affect deal terms.
Read original ↗
GlobeNewswire·82dRead more →
LCII

Halper Sadeh LLC Investigates ACA, TECH, IRDM, LCII Deals for Shareholder Fairness

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed acquisitions of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are fair to shareholders. The firm is examining Arcosa's sale to CRH for $150.00 per share, Bio-Techne's sale to Merck KGaA for $73.00 per share in cash, Iridium's sale to Rocket Lab for $27.00 in cash plus Rocket Lab shares, and LCI Industries' sale to Patrick Industries for 1.2440 shares of Patrick common stock per LCI share. Halper Sadeh may seek increased consideration or additional disclosures on behalf of shareholders, and encourages them to contact the firm at no cost to discuss their legal rights and options.
ACA · Capital · Neutral Investigation into fairness of Arcosa's sale to CRH at $150/share may lead to increased consideration or disclosures.
IRDM · Capital · Neutral Investigation into fairness of Iridium's sale to Rocket Lab for cash and shares may lead to improved terms.
LCII · Capital · Neutral Investigation into fairness of LCI Industries' sale to Patrick Industries for stock may lead to increased consideration.
TECH · Capital · Neutral Investigation into fairness of Bio-Techne's sale to Merck KGaA at $73/share may lead to improved terms.
Read original ↗
GlobeNewswire·91dRead more →
LCII2

Brodsky & Smith Investigating LCI Industries, Iridium, Bio-Techne, and Arcosa Mergers

Brodsky & Smith is investigating the boards of LCI Industries, Iridium Communications, Bio-Techne Corporation, and Arcosa over potential fiduciary duty breaches in their respective merger agreements. LCI is being acquired by Patrick Industries in an all-stock deal where LCI shareholders would receive 1.2440 Patrick shares per LCI share. Iridium is being acquired by Rocket Lab for $54 per share in cash and stock, with an enterprise value of approximately $8.0 billion. Bio-Techne is being acquired by Merck KGaA for $73.00 per share in cash, representing a total enterprise value of approximately $11.3 billion. Arcosa is being acquired by CRH for $150.00 per share in cash, with a total enterprise value of approximately $8.5 billion. The investigations focus on whether the boards failed to conduct a fair process and whether shareholders are receiving fair value.
ACA · Capital · Neutral Arcosa is being acquired by CRH; investigation into board's process creates uncertainty but deal is ongoing.
IRDM · Capital · Neutral Iridium is being acquired by Rocket Lab; investigation into board's process creates uncertainty but deal is ongoing.
LCII · Capital · Neutral LCI is being acquired by Patrick Industries; investigation into board's process creates uncertainty but deal is ongoing.
TECH · Capital · Neutral Bio-Techne is being acquired by Merck KGaA; investigation into board's process creates uncertainty but deal is ongoing.
Read original ↗
GlobeNewswire·91dRead more →
LCII▲5

LCI Industries and Patrick Industries agree to all-stock merger

LCI Industries and Patrick Industries have agreed to an all-stock merger to form a combined component supplier across outdoor recreation, housing, and transportation markets. The companies announced plans for a unified leadership structure and identified cost synergies as part of the proposed transaction. The deal remains subject to shareholder and regulatory approvals before it can close. LCI Industries shares are trading at $103.36, up 7.8% over the past week but down 16.9% year to date.
LCII · Capital · Positive LCI Industries is merging with Patrick Industries in an all-stock deal, expected to create synergies and value.
PATK · Capital · Positive Patrick Industries is merging with LCI Industries in an all-stock deal, expected to create synergies and value.
Read original ↗
Simply Wall St·94dRead more →
LCII

Halper Sadeh LLC Investigates Whether LCII, NUVL, DAN, TMHC Are Obtaining Fair Deals for Their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating LCI Industries, Nuvalent, Dana Incorporated, and Taylor Morrison Home Corporation for potential violations of federal securities laws or breaches of fiduciary duties to shareholders in connection with their proposed sales. The firm is examining LCI Industries' sale to Patrick Industries for 1.2440 shares of Patrick common stock per LCI share, Nuvalent's sale to GSK for $124.00 per share in cash, Dana's sale to Eaton Corporation where Dana shareholders would own approximately 49.9% of the combined company, and Taylor Morrison's sale to Berkshire Hathaway for $72.50 per common share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages them to contact the firm to discuss their rights at no cost.
DAN · Capital · Neutral Investigation into Dana's sale to Eaton for potential unfair deal terms; outcome uncertain.
LCII · Capital · Neutral Investigation into LCI's sale to Patrick Industries for potential unfair deal terms; outcome uncertain.
NUVL · Capital · Neutral Investigation into Nuvalent's sale to GSK for potential unfair deal terms; outcome uncertain.
TMHC · Capital · Neutral Investigation into Taylor Morrison's sale to Berkshire Hathaway for potential unfair deal terms; outcome uncertain.
Read original ↗
GlobeNewswire·97dRead more →
LCII▲

LCI Industries Earns Zacks Rank #2 and Value Grade A

LCI Industries currently holds a Zacks Rank #2, or Buy, and a Value grade of A, signaling it may be undervalued. The stock trades with a P/E ratio of 14.19, well below its industry average of 18.72, and its forward P/E has ranged from 10.65 to 19.04 over the past year. Its P/B ratio of 1.78 is also below the industry average of 4.18, while its P/S ratio of 0.56 compares favorably to the industry average of 0.71. These metrics, combined with a strong earnings outlook, suggest LCI Industries is a compelling value stock at this time.
LCII · Capital · Positive Zacks Rank #2 (Buy) and Value Grade A, with P/E, P/B, P/S below industry averages, signaling undervaluation.
Read original ↗
Zacks·101dRead more →